Proteomics

Dataset Information

0

Toxicity of the main electronic cigarette components, propylene glycol, glycerin and nicotine in Sprague Dawley rats in a 90-day OECD inhalation study complemented with molecular endpoints [LUNG DATA]


ABSTRACT: The main constituents of electronic cigarette liquids are nicotine, propylene glycol (PG), and vegetable glycerin (VG), together with distilled water and flavors. To assess the toxicity of PG/VG mixtures with and without nicotine as basic components of liquids used in e-cigarettes, a 90-day rat inhalation study according to the Organization for Economic Co-operation and Development test guideline 413 was conducted. Sprague-Dawley (SD) rats were nose-only exposed, 6 h/day, 5 days/week to filtered air, or nebulized vehicle (saline), or three concentrations of PG/VG (0.174 mg PG/l + 0.210 mg VG/l; 0.520 mg PG/l + 0.630 mg VG/l; 1.520 mg PG/l + 1.890 mg VG/l) – with (test item) and without (reference item) 23 µg nicotine/L. Standard toxicological endpoints were complemented by molecular analyses using transcriptomics, proteomics, and lipidomics. Compared to vehicle exposure, the tested PG/VG aerosols showed only very limited biological effects with no signs of toxicity, both for the standard toxicological endpoints (e.g., histopathology, clinical chemistry) and the systems toxicological analyses (transcriptomics, proteomics, and lipidomics). The addition of nicotine to the PG/VG aerosols (23 µg/l) resulted in effects in line with nicotine effects in previous studies. These included up-regulation of xenobiotic enzymes (Cyp1a1 and Fmo3) in the lung and metabolic effects, e.g., reduction in serum lipid concentrations and changes in the expression of metabolic enzymes in the liver. Signs of a generalized stress response to nicotine exposure such as decreased thymus weights were observed; and likely, a subset of the observed metabolic alterations was interlinked with this generalized stress response. Under the conditions of this 90-day SD rat inhalation study, no toxicologically relevant effects of PG/VG aerosols (up to 1.520 mg PG/l + 1.890 mg VG/l) were observed, and the no observed adverse effect level (NOAEL) for PG/VG/nicotine was determined to be 438/544/6.7 mg/kg/day. Further the study demonstrated how complementary systems toxicology analyses can reveal, also in the absence of observable adverse effects, subtoxic and adaptive responses to pharmacologically active compounds such as nicotine.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Rattus Norvegicus (rat)

TISSUE(S): Lung

SUBMITTER: Bjoern Titz  

LAB HEAD: Julia Hoeng

PROVIDER: PXD005959 | Pride | 2017-09-11

REPOSITORIES: Pride

Dataset's files

Source:
altmetric image

Publications

Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints.

Phillips Blaine B   Titz Bjoern B   Kogel Ulrike U   Sharma Danilal D   Leroy Patrice P   Xiang Yang Y   Vuillaume Grégory G   Lebrun Stefan S   Sciuscio Davide D   Ho Jenny J   Nury Catherine C   Guedj Emmanuel E   Elamin Ashraf A   Esposito Marco M   Krishnan Subash S   Schlage Walter K WK   Veljkovic Emilija E   Ivanov Nikolai V NV   Martin Florian F   Peitsch Manuel C MC   Hoeng Julia J   Vanscheeuwijck Patrick P  

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20170905 Pt 1


While the toxicity of the main constituents of electronic cigarette (ECIG) liquids, nicotine, propylene glycol (PG), and vegetable glycerin (VG), has been assessed individually in separate studies, limited data on the inhalation toxicity of them is available when in mixtures. In this 90-day subchronic inhalation study, Sprague-Dawley rats were nose-only exposed to filtered air, nebulized vehicle (saline), or three concentrations of PG/VG mixtures, with and without nicotine. Standard toxicologica  ...[more]

Similar Datasets

2017-09-11 | PXD005958 | Pride
2017-09-11 | PXD006894 | Pride
2017-11-03 | E-MTAB-5544 | biostudies-arrayexpress
2017-11-03 | E-MTAB-5545 | biostudies-arrayexpress
2017-11-03 | E-MTAB-5910 | biostudies-arrayexpress
2019-09-30 | E-MTAB-7893 | biostudies-arrayexpress
2023-01-06 | MSV000091015 | MassIVE
2021-09-07 | E-MTAB-10006 | biostudies-arrayexpress
2021-03-18 | E-MTAB-9597 | biostudies-arrayexpress
2021-08-16 | E-MTAB-7981 | biostudies-arrayexpress